Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective

Background: Little is known about the costs associated with vitamin K antagonist (VKA) treatment in patients with non-valvular atrial fibrillation (NVAF) in France. Objectives: To evaluate monthly per-patient costs attributable to VKA treatment in NVAF patients from a French societal perspective. St...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Mark Access Health Policy
Hlavní autoři: Levy, Pierre, Smadja, David, Dorey, Julie, Toumi, Mondher, Meinecke, Anna-Katharina, Bowrin, Kevin, Briere, Jean-Baptiste
Médium: Artigo
Jazyk:Inglês
Vydáno: Routledge 2019
Témata:
Original Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6374971/
https://ncbi.nlm.nih.gov/pubmed/30788086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2018.1564506
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky